Image

Evaluation of Clinical Success of Bulk Fil Composite Versus Highly Viscous Glass Ionomer in Primary Class II Molars

Evaluation of Clinical Success of Bulk Fil Composite Versus Highly Viscous Glass Ionomer in Primary Class II Molars

Recruiting
4-8 years
All
Phase N/A

Powered by AI

Overview

evaluate the clinical performance of EQUIA Forte ® ( a HVGIC) and Plafique® Bulk Flow composite resin when placed in class II cavities in primary molars.

Description

  1. Thorough diagnosis of patients will be done by the primary investigator. Patients with class II carious primary molars with score 4 or 5 using the International Caries Detections and Assessment Criteria (ICDAS).
  2. Pre-operative bitewing radiographs will be obtained to assess the depth of the cavity. Primary molars with score D1 or D2 according to the ADA will be included in the study.
  3. Each patient will be assigned to one of the two groups.
    • Group I (n= 59): Plafique Bulk Flow Composite.
    • Group II (n=59): EQUIA Forte Group. 4. Class II carious primary molars are prepared using 330 burs. The cavity will be approximately with a depth of 0.5 mm in dentin and width of at least one-third of the occlusal table. Outline of the cavity will be determined by the extent of the carious lesion. No beveling will be done in any of the cavities. 5. Matrix is placed and secured in position. 6. One of the 2 restorative materials is placed in the cavity using the manufacturer's instructions. 7. Patients will be recalled at 3, 6, and 12 months to evaluate the restoration clinically using the FDI criteria. 8. Patients will receive oral health education on how to maintain a proper oral hygiene and proper diet consumption. 9. They will be given manual tooth brushes and tooth pastes to use during the study.

Eligibility

Inclusion Criteria:

  • Four to 8 years old children
  • Cooperative children classified as class 3 or 4 based on Frankle et al. classification.
  • Presence of deep bite or any type of malocclusion or parafunctional habits.
  • Children who have at least one primary molar with active proximal caries (score 4 or 5 using ICDAS).

Exclusion Criteria:

  • Refusal of the parents to sign the informed consent.
  • Presence of deep bite or any type of malocclusion or parafunctional habits.

Study details
    Dental Caries Class II

NCT06235489

Ain Shams University

14 February 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.